Please Wait a Moment
X

Articles

07Aug

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

07 Aug, 2018 | Return|

CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.

Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications

Related

Confirmatory Testing Delay for HIV-1 Western Blot and HIV-2 EIA

Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...

Read More >

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >

FDA announces withdrawal of Guidance for ZIKV Testing

We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...

Read More >

Procedure for pouring off samples if shipments will be extremely delayed

As winter weather continues to move through parts of the US, we would like to remind you it may be n...

Read More >

Renewed NYSDOH licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >

Reminder- CTS Form Revisions Implement on September 2, 2019

Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...

Read More >